NCT07260175: Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 40 planned
- Started
- 18 Nov 2025
- Primary completion
- Dec 2030
- Arms
- Ivosidenib maintenance
- Results
- None posted
- 18 Nov 2025: Trial started
- 3 Dec 2025: Trial registered